Early Access — free while we kick the tires
EdgarHawk

Bohen Sean

PRESIDENT AND CEO

Director Officer
1 filing analyzed · 1 company · Latest 2024-12-11

Companies

Company Buys Sells Direction
Olema Pharmaceuticals, Inc. OLMA 0 4 Net selling

Activity

December 2024
high
Sell
109,502 shares
$986,365
Significance 6/10

CEO Sean Bohen sells 109.5K shares (31.2% of holdings) across 3 trades at blended avg $9.01; stock down 49.4% from 52-week high, company unprofitable.

Sean Bohen, President and CEO, executed 3 separate sales totaling 109,502 shares for $986,365.11 at an average of $9.01 per share on December 10–11, 2024, reducing his holdings by 31.2%. The transactions occurred as Olema's stock trades at $8.41, down 49.4% from its 52-week high of $16.62 and down 33.9% over the past 30 days—a period of severe price deterioration. Against this backdrop, the company reported a net loss of $34,555,000 for its most recent full fiscal year, reflecting ongoing unprofitability. While Bohen's cross-ticker sell track record shows a 33.33% well-timed rate with a positive average 90-day return of +0.7%, his prior trades specifically at OLMA show mixed timing results (1 of 3 well-timed at the 90-day mark). The combination of a large liquidation by the CEO, sustained stock decline, and negative fundamentals merits investor attention to assess whether this reflects a loss of confidence in near-term prospects or capital reallocation.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access